Lipidomics studies on macrophages
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PS(34:1) | KDO + ATP | 0.3 | MSH090825625 | 24.9 | pmol/ug DNA |
| - | PS(34:1) | KDO + ATP | 0.5 | MSH090825629 | 28 | pmol/ug DNA |
| - | PS(34:1) | KDO + ATP | 1.0 | MSH090825633 | 24 | pmol/ug DNA |
| - | PS(34:1) | KDO + ATP | 2.0 | MSH090825637 | 25.2 | pmol/ug DNA |
| - | PS(34:1) | KDO + ATP | 4.0 | MSH090825641 | 24 | pmol/ug DNA |
| - | PS(34:1) | KDO + ATP | 8.0 | MSH090825645 | 24 | pmol/ug DNA |
| - | PS(34:1) | KDO + ATP | 20.0 | MSH090825619 | 19.9 | pmol/ug DNA |
| - | PS(34:1) | KDO | 0.3 | MSH090825623 | 21.9 | pmol/ug DNA |
| - | PS(34:1) | KDO | 0.5 | MSH090825627 | 20.4 | pmol/ug DNA |
| - | PS(34:1) | KDO | 1.0 | MSH090825631 | 20.3 | pmol/ug DNA |
| - | PS(34:1) | KDO | 2.0 | MSH090825635 | 18.7 | pmol/ug DNA |
| - | PS(34:1) | KDO | 4.0 | MSH090825639 | 17 | pmol/ug DNA |
| - | PS(34:1) | KDO | 8.0 | MSH090825643 | 29.1 | pmol/ug DNA |
| - | PS(34:1) | KDO | 20.0 | MSH090825647 | 32.6 | pmol/ug DNA |
| - | PS(34:1) | C | 0.0 | MSH090825621 | 31.7 | pmol/ug DNA |
| - | PS(34:1) | C | 0.3 | MSH090825622 | 26 | pmol/ug DNA |
| - | PS(34:1) | C | 0.5 | MSH090825626 | 15.8 | pmol/ug DNA |
| - | PS(34:1) | C | 1.0 | MSH090825630 | 20 | pmol/ug DNA |
| - | PS(34:1) | C | 2.0 | MSH090825634 | 16.9 | pmol/ug DNA |
| - | PS(34:1) | C | 4.0 | MSH090825638 | 17.5 | pmol/ug DNA |
| - | PS(34:1) | C | 8.0 | MSH090825642 | 21.7 | pmol/ug DNA |
| - | PS(34:1) | C | 20.0 | MSH090825646 | 25.7 | pmol/ug DNA |
| - | PS(34:1) | ATP | 0.3 | MSH090825624 | 24.6 | pmol/ug DNA |
| - | PS(34:1) | ATP | 0.5 | MSH090825628 | 25.5 | pmol/ug DNA |
| - | PS(34:1) | ATP | 1.0 | MSH090825632 | 21.2 | pmol/ug DNA |
| - | PS(34:1) | ATP | 2.0 | MSH090825636 | 18.2 | pmol/ug DNA |
| - | PS(34:1) | ATP | 4.0 | MSH090825640 | 20.8 | pmol/ug DNA |
| - | PS(34:1) | ATP | 8.0 | MSH090825644 | 27.9 | pmol/ug DNA |
| - | PS(34:1) | ATP | 20.0 | MSH090825648 | 19 | pmol/ug DNA |